You are here: Industry Insights > COVID-19

News List

New collaboration between Novartis and Africa Medical Supplies Platform to facilitate supply of COVID-19 related medicines worldpharmanews
September 04, 2020
Novartis and the African Union (AU) through the Africa Medical Supplies Platform (AMSP) have announced a new collaboration to facilitate the supply of medicines from the Novartis Pandemic Response Portfolio to the AU member states and Caricom countries.
Hydrocortisone steroid improves COVID-19 patient chance of recovery, study shows europeanpharmaceuticalreview
September 04, 2020
A trial has shown that COVID-19 patients treated with the steroid hydrocortisone had a 93 percent chance of a better outcome from the coronavirus.
ADMA Biologics Launches COVID-19 ImmunoRank? Neutralization MICRO-ELISA Assay americanpharmaceuticalreview
September 04, 2020
ADMA Biologics announced the launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA assay for the detection of SARS-CoV-2 neutralizing antibodies in plasma.
WHO updates guidance on corticosteroids in Covid-19 patients pharmaceutical-technology
September 04, 2020
The World Health Organization (WHO) has updated its guidance on the use of corticosteroid drugs in patients with Covid-19 based on findings from a study data analysis.
Adma Biologics Launches COVID-19 Assay contractpharma
September 04, 2020
?Adma Biologics Inc., an end-to-end commercial biopharmaceutical company, has launched COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA assay for the detection of SARS-CoV-2 neutralizing antibodies in plasma.
Prep for COVID-19 vaccine distribution as soon as late October: US CDC expresspharma
September 04, 2020
An earlier report had informed that the CDC had contacted officials in all 50 states and five large cities with the planning information.
Steroid found to improve survival of critically ill COVID-19 patients worldpharmanews
September 03, 2020
A new international study published today has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery.
Orpheris enrols first patients in phase 2 clinical study evaluating OP-101 for severe Covid-19 pharmaceutical-business-review
September 03, 2020
O?rpheris announced enrollment of the first patients in its multicenter Phase 2 PRANA clinical study of the HDT, OP-101, to treat hospitalized adults with severe Covid-19.
Clear Creek Bio doses first patient in Covid-19 trial with brequinar pharmaceutical-business-review
September 03, 2020
Clear Creek Bio has dosed the first patient in phase 1 clinical study of brequinar in hospitalised patients with Covid-19.
Further clinical trials testing Kevzara as COVID-19 therapy to be halted europeanpharmaceuticalreview
September 03, 2020
After Kevzara (sarilumab) did not meet its primary or secondary endpoints in a Phase III trial, Sanofi and Regeneron have said they do not expect to conduct further studies on the drug against COVID-19.